XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Star of 49ers win, Mostert consoled injured teammate: “We’re brothers”

Raheem Mostert, who broke his arm against the Oakland Raiders in 2018, was able to empathize with some of the pain that Coleman was experiencing

Deal reached to purchase home at center of Moms 4 Housing protest

Oakland Community Land Trust to buy property under agreement with investment firm

The Niners faithful recall a different time as they celebrate their team’s victory

Minutes from Candlestick Park, the ancestral home of the 49ers, several of… Continue reading

The Niners are going to the Super Bowl

With a 37-20 win over the visiting Green Bay Packers, the 49ers punched their tickets to Miami, FL

‘Tough love’ continues to be an excuse for criminalizing homelessness

Mayor Breed needs to acknowledge the suffering caused by city sweeps

Most Read